BLACKROCK NEUROTECH
Live / Applied — Second extension granted (statement of use) (as of 29 Nov 2025)
What this means for you
Not registered yet, but its 20 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98322975
- Mark type
- Stylized text
- Filed
- 20 Dec 2023
- Published for opposition
- 22 Oct 2024
- Attorney of record
- Randall B. Bateman
Goods and services
- Class 042 — Scientific and technological services: Biotechnology research; Medical and scientific research in the field of Neuroscience, Neuromodulation and Neuroprosthetics; Medical and scientific research, namely, conducting clinical trials for others; Providing information about medical and scientific research; Research and development in the field of Neuroscience, Neuromodulation and Neuroprosthetics; Scientific and technological services, namely, research and design in the field of Neuroscience research, neural engineering, surgical procedures, neural prosthetics, and sensor technology; Scientific and technological services, namely, research and design in the field of medical devices and pharmaceuticals in the field of ophthalmology; Scientific and technological services, namely, research and design in the field of Neuroscience, Neuromodulation and Neuroprosthetics; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research in the field of Neuroscience, Neuromodulation and Neuroprosthetics; Scientific research and development; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of recording, analyzing, and storing signals from the central and peripheral nervous system in the field of neuroscience; Scientific research in the nature of conducting clinical trials for others in the field of medical devices and pharmaceuticals in the field of ophthalmology; Scientific research in the nature of conducting clinical trials for others in the field of Neuroscience, Neuromodulation and Neuroprosthetics; Scientific research services for others in the field of sensory perceptions
Owner
- Blackrock Microsystems, Inc., Salt Lake City, UT, US
- Blackrock Microsystems, Inc., Salt Lake City, UT, US
Prosecution history
- 29 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Nov 2025 — SOU EXTENSION 2 GRANTED
- 29 Nov 2025 — SOU EXTENSION 2 FILED
- 29 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 May 2025 — SOU EXTENSION 1 GRANTED
- 29 May 2025 — SOU EXTENSION 1 FILED
- 29 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Oct 2024 — PUBLISHED FOR OPPOSITION
- 02 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE